Anesthetized rats were treated with saline, antiinsulin receptor serum, or antiinsulin serum, and the biodistribution of high pressure liquid chromatography-purified '23I-Tyr A14-insulin was studied by scintillation scanning. Time activity curves over organs of interest were calibrated by sacrificing the rats at the end of the experiment and directly determining the radioactivity in the blood, liver, and kidneys. Saline-treated rats exhibited normal insulin biodistribution. The highest concentration of "HI-insulin was found in the liver, and reached 30% of total injected dose between 3 and 5 min after injection. After this peak, activity rapidly decreased with a t1/2 of 6 min. Activity of "23I-insulin in kidney showed a more gradual rise and fall and was -15% of injected dose at its maximum.
Introduction
We recently reported that the distribution of insulin can be studied in intact animals and in man using insulin labeled by the liver and kidneys. The liver; but not the kidney uptake, can be inhibited by simultaneous injection of unlabeled insulin, suggesting that it is receptor-mediated. Both organs then show characteristic patterns of clearance as the insulin is degraded and iodide is excreted in the urine.
This new technique offers a unique tool to study insulin resistance syndromes. Two of the best characterized syndromes of insulin resistance are those that occur in patients who develop antibodies to insulin (3, 4) or antibodies to the insulin receptor (5, 6) . Both of these syndromes present characteristic clinical features, and the antibodies that produce them have been extensively studied in vitro. Most information about the mechanisms by which these two types of antibodies produce insulin resistance, however, is based on extrapolation of the in vitro data to the in vivo situation. In the first case, insulin is presumed to be bound to circulating immunoglobulins, thus preventing its access to receptors on target cells. In the second, insulin also fails to reach receptors on target cells, but in this case, the blockade is presumably at the receptor itself. Thus, one would predict that the biodistribution of insulin in these two syndromes would have some similarities and some differences. In this report, we have studied these two models of insulin resistance in vivo using the scintillation scanning technique, and have also characterized the cellular distribution of antibody-bound insulin in liver using light microscopic autoradiography.
Methods
Materials. Purified bovine insulin (0.1 mg; Novo Industrie A. S., Copenhagen, Denmark) was labeled with 5 mCi '23I-NA and the species monoiodinated on TyrA,4 was rapidly purified by high pressure liquid chromatography (1, 7) . Bovine insulin was iodinated with 125I in a similar manner and also purified by high pressure liquid chromatography. Antiserum to the insulin receptor (AIRS)' was from patient B2 and was previously well characterized (6, 8, 9) . This serum has been shown to contain no detectable anti-insulin antibodies but has a high titer of anti-receptor antibodies. The anti-insulin serum (AIS) used for these experiments was prepared by P. H. Wright (Indianapolis, IN) by immunizing guinea pigs against bovine insulin and was a gift from Dr. J. S. Soeldner (Boston, MA).
Biodistribution and scintillation scanning. Fed male Sprague-Dawley rats weighing 225-275 g were anesthetized with pentobarbital (60 mg/ kg i.p.) and a PE50 polyethylene tube was introduced into the jugular vein. Rats were laid in the prone position on the collimator of a scintillation camera (Searle Large Field of View; Des Plaines, IL) connected to a computer (Gamma 11; Digital Equipment Corp., Marlboro, MA) or a 400 T Maxicamera connected to a Star Computer (General Electric Medical Systems, Denmark). Rats received saline, AIS (150-250 !l), or AIRS (4-40 Ml) 5-10 min before injection of l23I_ insulin (50-100 MCi). Immediately after the intravenous bolus of 123I1 insulin, sequential frames were recorded by the computer at a rate of one per 30 s for 30 min. At the end of the recording period, the animals were bled by heart puncture, sacrificed, and their organs were rapidly dissected. A 1-min static frame of the carcass and isolated liver, spleen, kidneys, and stomach was then recorded and used to measure the percentage of radioactivity in the liver and kidneys at 30 min.
Computer analysis of kinetic data was performed as previously described (2) . Briefly, the actual injected radioactivity (microcuries) was measured by counting the activity of the '23I-insulin-containing syringe before and after injection. Using the static frame taken at 30 min, the apparent radioactivity (cpm) of the isolated kidneys, liver, stomach, and remaining carcass was measured, and the sum of these values was taken as 100% of injected radioactivity. The percentage of radioactivity in the liver and kidney at 30 min was calculated. Regions of interest were defined over the right upper part of the liver and the lower pole of each kidney and time-activity curves were generated. After background subtraction, the ordinate of each curve was calibrated using the percentage of radioactivity in the corresponding organs at 30 min.
Anti-insulin and anti-receptor antibody assays. Blood samples taken at 30 min were immediately centrifuged and the serum was stored at -250C for at least 1 wk to ensure complete decay of the 1231. The sera were then analyzed for antiinsulin receptor or anti-insulin antibodies.
Quantitation of the anti-insulin receptor antibody level in the rat serum was performed using the binding inhibition assay (5, 8) . For this assay, serum from a control rat and from rats injected with antireceptor serum was preincubated with IM-9 lymphocytes at 370C for 15 min, after which 121I-insulin was added and the cell suspensions were further incubated for 30 min. At the end of the incubation, cells were isolated by centrifugation and cell bound radioactivity was measured. Anti-insulin antibody level in the rat serum was measured by incubating serial dilutions of serum with '25l-insulin at 40C overnight, after which activated charcoal was added, the tubes were centrifuged, and the percentage of antibody bound radioactivity was measured in the supernate (10) . Autoradiography. To determine to which liver cell type radioactivity was bound, two control and two AIS-treated rats received 0.5 gCi/g '1251-insulin. 9 min later, the animals were sacrificed, their livers were dissected, fixed, and sectioned, and autoradiographs were prepared as previously described (11) (12) . Criteria of homoskedasticity were satisfied by log transformation of the variables and statistical differences were determined with the Snedecor (F) test in the BMDP program (12) .
Results
Effects of antiinsulin serum on biodistribution of '23I-insulin. The biodistribution of insulin in control (saline-treated) rats is illustrated in Fig. I (left rat of each pair). 3 min after injection of '23I-insulin, radioactivity was predominately concentrated by the liver and kidneys ( Fig. 1 A, left) . We have previously shown that most of this hepatic uptake is receptor-mediated and is blocked by saturation with excess unlabeled insulin (1) . By contrast, renal uptake seems to be largely nonreceptormediated and actually increases after injection of unlabeled insulin. At later times, liver activity decreased and by 30 min (Fig. 1 D, left) the pattern of distribution became similar to that of free iodide, i.e., most of the radioactivity was in the bladder and stomach. Pretreatment of the rat with antiinsulin markedly altered the distribution of serum '231-insulin (right rat of each pair). By 3 min after injection, almost all of the '231-insulin was concentrated in the liver (Fig. 1 A, right) . This pattern remained unchanged at later times (Fig. I B, C , and D), and at no time were the kidneys, bladder, and stomach visualized.
The kinetics of hepatic uptake of 1231-insulin and the effect of AIS is further demonstrated by Fig. 2 . In control rats, the maximum of liver activity was 30% at 3-4 min. Past this maximum, liver activity rapidly decreased with a t1/2 of -6 min. After injection of 4 or 40 ul of AIS, liver activity rapidly rose to 50 or 90% of total injected, respectively. Liver activity then remained at this plateau value throughout the 30-min observation period. Both the difference in peak uptake and kinetics of disappearance were highly significant (mean of control vs. 4 ,l AIS was F = 418, P < 0.0001; mean of control vs. 40 ,l AIS was F = 923, P < 0.0001; interaction between groups and time were F = 38.7 and F = 55.4, respectively, both P < 0.0001). In contrast to the increased hepatic uptake, kidney uptake was decreased after 4 ,ul of AIS and abolished with 40 ,l (Fig. 3 ) (F = 13.7, P < 0.004).
Quantitation of antibodies remaining in the serum of the rats 40 min after injection of AIS indicated that the rats injected with 40 ,gl AIS possessed significant titers of antibody (Fig. 4) . The titer at the end of the experiment was only about 0.1% that of the original antiserum or about a third of that predicted by dilution, suggesting that much of the antibody had been cleared. In rats injected with 4 tl AIS, anti-insulin antibodies were barely detectable at 40 min after injection (Fig. 4) .
In view of the marked hepatic uptake and difference in kinetics, autoradiographic studies were performed to determine the cellular localization of the insulin. In the livers of control rats, the autoradiographic grains were predominantly associated with the hepatocytes (Fig. 5 A) . By contrast, in the rats that received AIS, the grains were almost exclusively localized over Kuppfer cells (Fig. 5 B) .
Effect of antiinsulin receptor serum on the biodistribution of '23I-insulin. Fig. 6 illustrates the effect of AIRS on 1231_ insulin biodistribution. In each panel, the rat on the left side of the field was treated with saline and exhibits the same pattern of activity distribution as in nontreated controls, whereas that on the right was pretreated with 250 ul of antireceptor serum B2 (AIRS). In the rat pretreated with 250 ul AIRS, the liver was not visible on the 3-min image but the kidneys were conspicuous (Fig. 6 A, right) . At later times, the kidneys remained visible and evidence for free iodide appearance, i.e., activity in the stomach and bladder, became prominent, but little activity appeared in the liver. This effect of AIRS was confirmed by examining liver time activity curves (Fig. 7) . In the presence of 250 g1 AIRS, liver activity was reduced to 9% at 3 min compared with 30% in control rats (F = 32.8, P = 0.0003). Injection of a lower dose of AIRS (100 ul) had less of an effect on liver '231-insulin uptake and the liver activity profile was indistinguishable from that of control rats (F = 2.85, P = 0.12 for comparison of group means). By contrast, the two doses of AIRS increased kidney activity in a dose-dependent manner (Fig. 8) The actual titers of antibodies to the insulin receptor in the serum of rats pretreated with serum of patient B2 were determined by titrating a serum sample taken immediately after sacrifice. As shown by Fig. 9 , the serum from rats injected with 250 p1 of antiserum inhibited 1251-insulin binding to IM-9 lymphocytes in vitro, whereas the serum of a rat injected with 100 p1 antiserum was not significantly different from control. The small effect of the control serum compared with our previous studies is probably the result of the modified (16) . The biological half-life of radioactivity in the liver using this method is short, 6 min, a figure that agrees with a previous estimate obtained by sequential measure of actual liver '25I-insulin (17) . As recently noted, there is thus a marked discrepancy between the kinetics of insulin degradation in the liver and that of deactivation of insulin effects in the same organ (18) . Figure 8 . Effect of AIRS on kidney activity. Profile of kidney radioactivity in rats previously treated with either 100 (n = 2, *) or 250 (n = 2, *) Ml antiinsulin receptor serum. Comparison with Fig. 3 shows that kidney uptake of radioactivity was enhanced by AIRS in a doserelated manner.
High titers of anti-insulin antibodies produce an insulinresistant state; however, the exact mechanism is unclear. Antibodies may bind insulin and thus prevent access of insulin and ., 250 Ml AIRS). The serum samples were drawn by heart puncture immediately at the end of the 30-min recording period, i.e., ±40 min after AIRS injection, and the titer of antibody was determined by the binding inhibition assay described in Methods. In the absence of any serum, cells bound 11% of the tracer. Nonspecific binding was 4%. The inhibition of 25I-insulin binding by the serum of 250 Ml AIRS-treated rats was not due to hyperinsulinemia, since plasma immunoreactive insulin concentration was similar in control and experimental rats.
to its target tissues (3, 4) . Alternatively, the immune complexes may be cleared without releasing their insulin, thus creating a new pathway of insulin loss (19) . In this study, we find that antibody-bound insulin rapidly disappears from the circulation. In these passively immunized rats, '23I-insulin was taken up by the liver in increasing amounts in proportion to the dose of AIS. Furthermore, after the first 5 min, liver activity did not decrease as in control rats, but remained constant throughout the remainder of the experiment. The most likely explanation for these two observations is that '23I-insulin-immune complexes, and not free '23I-insulin, reacted with the liver. As recently shown by Maron et al. (19a) and Taylor et al. (20) , when insulin binds to its receptors, some of the hormone remains accessible to anti-insulin antibody but the majority of the insulin molecule is unavailable for binding to anti-insulin antibodies, probably because most of the insulin molecule is sequestered in the receptor. Conversely, it may be inferred that insulin bound to most antibodies is unavailable for receptor binding. This is consistent with our finding that the 1231-insulin immune complexes bind poorly to hepatocytes, and autoradiographs of the liver of passively immunized rats show that under these conditions radioactivity is almost exclusively associated with the Kuppfer cells. Thus, the trigger for 1231-insulin clearance by the liver is no longer the hormone itself binding to its receptors on hepatocytes, but probably the Fc fragment of the insulin-immune complexes binding to Fc receptors on macrophages.
Anti-insulin receptor antibodies have been shown to block insulin binding in vitro (5, 9) and to alter insulin action both in vitro (9, 21, 22) and in vivo (23) . The biological effects of the antibody are complex, mimicking insulin action acutely (9, 21, 22, 23) , and inducing a state of insulin resistance after more prolonged exposure (21, 23) . The serum of patient B2 used in these experiments has been well characterized and is shown to have a high titer of anti-receptor antibodies that react specifically with insulin receptors on a wide variety of cells with little or no anti-insulin antibodies (5, 6, 9) . After pretreatment with 250 gl of this serum, liver uptake of 123I-insulin was almost completely abolished in the rat. With this concentration of antiserum, free antibodies were still detectable in the rat serum at the end of the experiment, indicating that antibodies were in excess with regard to receptors. The lower dose of AIRS had no visible effect on '23I-insulin uptake by the liver, suggesting that specific receptors in this organ are in excess with regard to circulating insulin.
The kidneys also play an important role in clearance of plasma insulin, although by a more complex mechanism (24). Some antibodies have an insulin 'scavenging' effect similar to that observed in passively immunized rats, whereas antibodies taken from other patients primarily retard the clearance of insulin from the plasma (27) . Thus, it seems that there is more than one type of antibody to insulin and these affect insulin bioavailability and metabolism differently, perhaps depending on their affinity, the epitope(s) of insulin with which they react, and perhaps also depending on the immunoglobulin subclass (Sodoyez, J. C., E. R. Arquilla 
